These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26315962)

  • 1. Radiologic damage at baseline predicts patient-related outcomes 18 years after the initiation of methotrexate therapy in patients with severe rheumatoid arthritis.
    Krause D; Gabriel B; Herborn G; Braun J; Rau R
    Clin Exp Rheumatol; 2015; 33(5):611-6. PubMed ID: 26315962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to methotrexate predicts long-term patient-related outcomes in rheumatoid arthritis.
    Krause D; Gabriel B; Herborn G; Braun J; Rau R
    Clin Rheumatol; 2016 May; 35(5):1123-7. PubMed ID: 26920753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misclassification of disease activity when assessing individual patients with early rheumatoid arthritis using disease activity indices that do not include joints of feet.
    Bakker MF; Jacobs JW; Kruize AA; van der Veen MJ; van Booma-Frankfort C; Vreugdenhil SA; Bijlsma JW; Lafeber FP; Welsing PM
    Ann Rheum Dis; 2012 Jun; 71(6):830-5. PubMed ID: 22128075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of power Doppler ultrasound for prediction of re-therapy with rituximab in rheumatoid arthritis: a prospective study of longstanding rheumatoid arthritis patients.
    Reiche BE; Ohrndorf S; Feist E; Messerschmidt J; Burmester GR; Backhaus M
    Arthritis Care Res (Hoboken); 2014 Feb; 66(2):204-16. PubMed ID: 23925935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to methotrexate predicts long-term mortality of patients with rheumatoid arthritis independent of the degree of response: results of a re-evaluation 30 years after baseline.
    Krause C; Herborn G; Braun J; Rudolf H; Wassenberg S; Rau R; Krause D
    Clin Exp Rheumatol; 2017; 35(3):384-389. PubMed ID: 27974101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated joint space width quantification of hand and wrist joints: a proof of concept study.
    Huo Y; Veldhuizen RD; van der Heijde DM; Besselink NJ; Jacobs JW; van Laar JM; Viergever MA; Vincken KL; Lafeber FP; de Hair MJ;
    Clin Exp Rheumatol; 2016; 34(5 Suppl 101):S34-S39. PubMed ID: 27762190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.
    Nordal HH; Brun JG; Hordvik M; Eidsheim M; Jonsson R; Halse AK
    Scand J Rheumatol; 2016 Jul; 45(4):274-81. PubMed ID: 26767827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of radiographic joint damage in rheumatoid arthritis patients in DAS28 remission using single- or combined with methotrexate non biological disease-modifying antirheumatic drug therapy in routine clinical practice.
    Katayama K; Okubo T; Sato T; Ito H; Fukai R; Baba H
    Mod Rheumatol; 2015 Jan; 25(1):50-5. PubMed ID: 24983407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating processes underlying the predictive value of baseline erosions for future radiological damage in early rheumatoid arthritis.
    van Nies JA; van Steenbergen HW; Krabben A; Stomp W; Huizinga TW; Reijnierse M; van der Helm-van Mil AH
    Ann Rheum Dis; 2015 May; 74(5):883-9. PubMed ID: 24431393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial.
    Rantalaiho V; Korpela M; Laasonen L; Kautiainen H; Järvenpää S; Hannonen P; Leirisalo-Repo M; Blåfield H; Puolakka K; Karjalainen A; Möttönen T;
    Arthritis Res Ther; 2010; 12(3):R122. PubMed ID: 20576092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive value of the HLA shared epitope for severity of radiological joint damage in patients with rheumatoid arthritis. A 10 year observational prospective study.
    Valenzuela-Castaño A; García-López A; Pérez-Vilches D; Rodriguez-Pérez R; Gonzalez-Escribano MF; Núñez-Roldán A
    J Rheumatol; 2000 Mar; 27(3):571-4. PubMed ID: 10743791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longterm safety, efficacy, and inhibition of structural damage progression over 5 years of treatment with abatacept in patients with rheumatoid arthritis in the abatacept in inadequate responders to methotrexate trial.
    Kremer JM; Peterfy C; Russell AS; Emery P; Abud-Mendoza C; Sibilia J; Becker JC; Westhovens R; Genant HK
    J Rheumatol; 2014 Jun; 41(6):1077-87. PubMed ID: 24786925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of CXCL13 as a marker for rheumatoid arthritis outcome using an in silico model of the rheumatic joint.
    Meeuwisse CM; van der Linden MP; Rullmann TA; Allaart CF; Nelissen R; Huizinga TW; Garritsen A; Toes RE; van Schaik R; van der Helm-van Mil AH
    Arthritis Rheum; 2011 May; 63(5):1265-73. PubMed ID: 21305530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of radiographic joint damage in rheumatoid arthritis: independence of erosions and joint space narrowing.
    Smolen JS; van der Heijde DM; Aletaha D; Xu S; Han J; Baker D; St Clair EW
    Ann Rheum Dis; 2009 Oct; 68(10):1535-40. PubMed ID: 18957487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The positive influence of methotrexate on the mortality of patients with rheumatoid arthritis is partly independent of its effect on disease activity: results of a re-evaluation 18 years after baseline.
    Krause D; Gabriel B; Herborn G; Braun J; Rau R
    Clin Exp Rheumatol; 2014; 32(3):395-400. PubMed ID: 24773941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study.
    Korpela M; Laasonen L; Hannonen P; Kautiainen H; Leirisalo-Repo M; Hakala M; Paimela L; Blåfield H; Puolakka K; Möttönen T;
    Arthritis Rheum; 2004 Jul; 50(7):2072-81. PubMed ID: 15248204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project.
    Backhaus M; Ohrndorf S; Kellner H; Strunk J; Backhaus TM; Hartung W; Sattler H; Albrecht K; Kaufmann J; Becker K; Sörensen H; Meier L; Burmester GR; Schmidt WA
    Arthritis Rheum; 2009 Sep; 61(9):1194-201. PubMed ID: 19714611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The methotrexate therapeutic response in rheumatoid arthritis.
    Ortendahl M; Holmes T; Schettler JD; Fries JF
    J Rheumatol; 2002 Oct; 29(10):2084-91. PubMed ID: 12375316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of understanding radiographic findings in relation to clinical outcomes in rheumatoid arthritis.
    Keystone EC
    J Rheumatol Suppl; 2009 Jun; 82():11-6. PubMed ID: 19509325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining erosive disease typical of RA in the light of the ACR/EULAR 2010 criteria for rheumatoid arthritis; results of the data driven phase.
    Knevel R; Lukas C; van der Heijde D; Rincheval N; Combe B; van der Helm-van Mil AH
    Ann Rheum Dis; 2013 Apr; 72(4):590-5. PubMed ID: 23393145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.